Table 1 Clinical characteristics of patients.
Variable | Number (%) | Variable | Number (%) |
|---|---|---|---|
Total | 295 (100) | Differentiation | |
Median age (years) | 55 | High | 62 (21.0) |
Median BMI | 22.66 | Medium | 127 (43.1) |
Figo stage | Low | 106 (35.9) | |
IIB | 118 (40.0) | Complication | |
IIIA | 14 (4.7) | Hypertension | 50 (16.9) |
IIIB | 85 (28.8) | Diabetes | 23 (7.8) |
IIIC1 | 59 (20.0) | Others | 38 (12.9) |
IIIC2 | 19 (6.4) | Chemotherapy cycles | |
Pathology | 1–3 | 44 (14.9) | |
Squamous carcinoma | 280 (94.9) | 4–6 | 251 (85.1) |
Adenocarcinoma | 13 (4.4) | Chemotherapy | |
Adenosquamous carcinoma | 2 (0.7) | Carboplatin | 10 (3.4) |
Tumor diameter | Cisplatin | 87 (29.5) | |
< 4 cm | 131 (44.4) | Nedaplatin | 198 (67.1) |
≥ 4 cm | 164 (55.6) | Radiotherapy | |
Conventional radiotherapy | 217 (73.56) | ||
Extended-field radiotherapy | 78 (26.44) | ||
